NERV Minerva Neurosciences, Inc.: institutional ownership and insider trading
61 funds reported holding $261M of Minerva Neurosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $17.6M, with 22 new positions and 8 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
NERV revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income $17.5M, EPS -0.14
- Quarter ended Mar 31, 2026: revenue n/a, net income −$125M, EPS -2.86
- Quarter ended Dec 31, 2025: revenue n/a, net income −$284M, EPS -33.38
- Quarter ended Sep 30, 2025: revenue n/a, net income −$2.74M, EPS -0.36
Famous investors holding NERV
- Izzy Englander (Millennium Management): $2.96M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $407K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $142K, 0.0% of the portfolio
Largest institutional holders of NERV
- FEDERATED HERMES, INC. (FHI) — $25.9M
- JANUS HENDERSON GROUP PLC (JHG) — $25.9M
- Jupiter Topco LLC — $24.3M
- Vivo Capital, LLC — $24.0M
- BALYASNY ASSET MANAGEMENT L.P. — $23.6M
- Logos Global Management LP — $18.3M
- FARALLON CAPITAL MANAGEMENT, L.L.C. — $13.1M
- BlackRock, Inc. (BLK) — $12.4M
- Ally Bridge Group (NY) LLC — $12.1M
- Foresite Capital Management VI LLC — $11.0M
5%+ owners
- Federated Hermes, Inc.: 17.2% (Schedule 13G/A, filed Jul 8, 2026)
- BALYASNY ASSET MANAGEMENT L.P.: 10.0% (Schedule 13G/A, filed Aug 14, 2026)
- JANUS HENDERSON GROUP PLC: 9.9% (Schedule 13G, filed May 15, 2026)
- Farallon Capital Management, L.L.C.: 9.7% (Schedule 13G/A, filed Aug 13, 2026)